Imatinib effect on K562 leukemia cell line (VI) - - GEO DataSets - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

Result Filters

Summary

Format

Summary
Summary (text)
Unique Identifier List

Send to:

Choose Destination

File
Clipboard
Collections

Links from GEO Profiles

Full record GDS3047

Imatinib effect on K562 leukemia cell line (VI)

Analysis of K562 leukemia cells treated with 1 uM imatinib for 24 hours. Imatinib is a highly selective and potent growth-inhibitor of BCR/ABL1 expressing cells such as K562. Results provide insight into molecular mechanisms underlying BCR/ABL1-mediated leukemogenesis.

Organism:: Homo sapiens

Type:: Expression profiling by array, transformed count, 2 agent sets

Platform:: GPL96
Series:: GSE1922
6 Samples

Download data: CEL

DataSet

Accession:: GDS3047

ID:: 3047

GEO Profiles Analyze DataSet

Supplemental Content

Related information

GEO Profiles
Related GEO
BioProject
BioProject links
GEO DataSets
Related GEO DataSets
Taxonomy
Taxonomy

Important Links

Recent activity

Clear Turn Off Turn On

Imatinib effect on K562 leukemia cell line (VI)
Imatinib effect on K562 leukemia cell line (VI)
Accession: GDS3047

GEO DataSets
Related DataSets for GEO Profiles (Select 47259102) (1)
GEO DataSets

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

You are here: NCBI > Genes & Expression > Gene Expression Omnibus (GEO) Datasets